About Neosoma
Neosoma is a medical technology company specializing in AI-based software for brain tumor analysis from MRI scans. The company’s cloud-native platform is designed to assist multidisciplinary neuro-oncology clinical teams, researchers, and clinical trials. It offers a portfolio of highly optimized, indication-specific software medical devices that map, measure, and track tumor compartments and lesions longitudinally, providing near real-time insights to support clinical decisions and research.
Neosoma’s technology integrates with PACS, is interoperable with radiation treatment and surgical planning systems, and is SOC2 Type II certified and HIPAA compliant. Their products, such as Neosoma Glioma and Neosoma Brain Mets, are FDA cleared. Neosoma Glioma is intended for the semi-automatic labeling, visualization, and volumetric quantification of high-grade brain glioma from standard MRI images of adult patients with pathologically proven high-grade glioma. Neosoma Brain Mets uses an AI algorithm to contour known or previously diagnosed brain tumors on MRI images for qualified medical professionals, providing precise and accurate brain tumor analysis. This technology aims to improve clinical outcomes, increase efficiency, and reduce costs in neuro-oncology.
Neosoma’s software is designed to help physicians better plan procedures, assess post-procedural results, guide treatments, track patients, and support an improved patient experience. The platform provides objective data to make treatment decisions easier and more accurate, especially for complex cases like glioblastomas, which have irregular shapes that are difficult to delineate manually. The company’s solutions are priced based on MRI volume, allowing all multidisciplinary team members to have access without incremental seat licenses.
Focus Areas
Business Intelligence
| Technology | Cloud-native, AI-based image analysis and decision-making platform for neuro-oncology, PACS-integrated, interoperable with radiation treatment and surgical planning systems, SOC2 Type II certified, HIPAA compliant, web-based interface |
What Physicians Need to Know
Neosoma's AI-powered platform provides quantitative, 3D insights into brain tumor changes, aiding in treatment planning, longitudinal tracking, and clinical decision-making. The software automates tumor segmentation and volumetric measurements, which can significantly reduce the time spent on manual assessments and enhance the application of treatment response criteria. It is designed to be a valuable complement to expert clinical judgment, providing objective data for tumor boards and patient counseling. The platform is PACS-integrated and interoperable with radiation treatment and surgical planning systems, streamlining workflows. Physicians can utilize the interactive charts, 3D/2D visualizations, and smart editing tools for comprehensive analysis and patient communication. Neosoma's technology is tolerant of real-world MRI data and does not require changes to acquisition protocols. While it offers significant efficiency and standardization, it's important to remember that the software is for informational purposes and not intended for primary diagnosis or to replace manual contouring practices.
Neosoma's cloud platform is PACS-integrated, allowing for automated sending of DICOM studies for analysis and one-click deep linking to jump from PACS to Neosoma's system. It is interoperable with various radiation treatment planning systems such as Eclipse, MIM, Gamma Plan, and Stealth, enabling easy import of lesion contours (GTVs). The platform is web-based for secure access and is SOC2 Type II certified and HIPAA compliant.
Reviews & Opinions
Videos
News, demos, and interviews about Neosoma.
Videos load interactively. If none appear, search YouTube for Neosoma →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Neosoma.
Comparisons
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]